Arysta Lifescience India Limited, a active public limited company, was established on 07 November 1949 in Mumbai, Maharashtra, India. Engaging in crop protection within the manufacturing sector, it holds CIN: U51420MH1949PLC007856. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹105.00 Cr and a paid-up capital of ₹4.98 Cr.
Formerly known as Devidayal (Sales) Limited. It upholds a compliant status. Employing 254 professional, Its leadership includes Sameer Tandon (Director), Meena Deepak Ved (Director), Swati Sandesh Mayekar (Director). Past directors included Sujata Chattopadhyay, Sameer Tandon, Hisaya Kobayashi. Its latest AGM occurred on 29 September 2025, with the balance sheet filed on 31 March 2025. It is based at Uniphos House, 11Th Road , Opp Madhu Park, Khar (W),, Mumbai, Maharashtra, 400052.
U51420MH1949PLC007856
007856
07 November 1949
₹105.00 Cr
₹4.98 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Arysta Lifescience India Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sameer Tandon | Director | 13 Jan 2020 | Current |
| Meena Deepak Ved | Director | 18 May 2020 | Current |
| Swati Sandesh Mayekar | Director | 18 May 2020 | Current |
| Ashish Dobhal | Director | 07 Jul 2019 | Current |
| Ravishankar Cherukuri | Additional Director | 17 Nov 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 31 Mar 2020 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2020 | Past |
| Pramod Abcsdd | Additional Director | 30 Dec 2016 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2020 | Past |
| Pramod Abcsdd | Additional Director | 30 Dec 2016 | Past |
| Pramod Abcsdd | Managing Director | 15 Mar 2013 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Arysta Lifescience India Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 38.45% increase. The company also saw a substantial improvement in profitability, with a 152.61% increase in profit. The company's net worth Soared by an impressive increase of 66.22%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Arysta Lifescience India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Arysta Lifescience India has a workforce of 254 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Arysta Lifescience India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Arysta Lifescience India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Ravishankar Cherukuri was appointed as a Additional Director was appointed as a Additional Director on 17 Nov 2025 & has been associated with this company since 2 months . was recorded as a recent event.
Arysta Lifescience India Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records. was recorded as a recent event.
Progress on Arysta Lifescience India Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.
The activity Meena Deepak Ved was appointed as a Director was appointed as a Director on 18 May 2020 & has been associated with this company since 5 years 7 months . was completed.
Progress on Swati Sandesh Mayekar was appointed as a Director was appointed as a Director on 18 May 2020 & has been associated with this company since 5 years 7 months . was documented.
Progress on Sameer Tandon was appointed as a Director was appointed as a Director on 13 Jan 2020 & has been associated with this company since 6 years 3 days . was documented.
UPL Ltd and PI Industries Ltd gained 17-28% in FY19, Rallis India Ltd and Dhanuka Agritech lost between 28% and 30% of their value.Shares of agrochemical companies with higher exposure to overseas markets have done better than those with less exposure in FY19.
The CIN of Arysta Lifescience India Limited is U51420MH1949PLC007856.
Arysta Lifescience India Limited is headquartered at Uniphos House, 11Th Road , Opp Madhu Park, Khar (W),, Mumbai, Maharashtra, 400052.
Arysta Lifescience India Limited was incorporated on 07 November 1949.
The current directors of Arysta Lifescience India Limited are
The primary industry of Arysta Lifescience India Limited is Manufacturing.
Arysta Lifescience India Limited is unlisted.
The authorized capital of Arysta Lifescience India Limited is ₹105.00 Cr, and the paid-up capital is ₹4.98 Cr.
The compliance status of Arysta Lifescience India Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX